|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of CRISPR Therapeutics (NASDAQ: CRSP) through any online brokerage.
There are no as such competitors for CRISPR Therapeutics.
The latest price target for CRISPR Therapeutics (NASDAQ: CRSP) was reported by Barclays on 2021-04-21. The analyst firm set a price target for 160.00 expecting CRSP to rise to within 12 months (a possible 48.56% upside). 18 analyst firms have reported ratings in the last year.
The stock price for CRISPR Therapeutics (NASDAQ: CRSP) is $107.7 last updated Fri May 07 2021 20:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for CRISPR Therapeutics.
There is no upcoming split for CRISPR Therapeutics.